Top 15 Differential Diagnosis for 32-year-old female, not pregnant, with typical or atypical symptoms of Diffuse Hair Loss On Her Scalp, Increased Hair Growth On Her Arms And Face, History Of Amenorrhea And Deepening Of Her Voice, Muscular Habitus, Bitemporal Recession Of The Hairline And Prominent Balding At The Vertex, With Miniaturization Of The Hairs, Scaling And Mild Erythema Are Also Noted Throughout The Scalp, Velvety Thickening And Tannish Discoloration Of The Lateral Neck, Clitoromegaly, Low Luteinizing Hormone, Low Follicle Stimulating Hormone, High 17 Hydroxyprogesterone, High Free Testosterone, High Total Testosterone.

Reading File

Finding Sources

Reading File

I now have comprehensive information from the textbooks. Let me synthesize the full differential diagnosis.

Top 15 Differential Diagnoses

Clinical Summary: 32-year-old non-pregnant female with virilization (clitoromegaly, voice deepening, muscular habitus), bitemporal/vertex androgenetic alopecia with miniaturization, hirsutism (face/arms), acanthosis nigricans (lateral neck — velvety tannish thickening), scalp scaling/erythema, amenorrhea, low LH, low FSH, elevated 17-OHP, elevated free and total testosterone.

The combination of markedly elevated testosterone + low gonadotropins + high 17-OHP + full virilization in a reproductively-aged woman drives a narrow, high-yield differential centered on androgen-secreting tumors, enzymatic defects, and severe hyperandrogenic syndromes. The scalp scaling/erythema adds a dermatologic overlay (seborrheic dermatitis-like picture from androgen excess).

1. Ovarian Androgen-Secreting Tumor (Sertoli-Leydig Cell Tumor)

Most likely diagnosis. Sertoli-Leydig cell tumors are the classic cause of rapid-onset, complete virilization in a reproductive-aged woman. They produce testosterone and sometimes androstenedione directly. Total testosterone > 200 ng/dL is highly suspicious for an ovarian or adrenal neoplasm. LH/FSH are suppressed via negative feedback from the excess androgen/estrogen milieu. The full triad of clitoromegaly, voice deepening, and bitemporal recession with vertex balding is the textbook presentation.

Key labs: Very high total testosterone (often > 200 ng/dL), suppressed LH/FSH, normal to mildly elevated DHEAS
Workup: Pelvic ultrasound or MRI; inhibin B may be elevated — Fitzpatrick's Dermatology, Vol. 1/2 | Berek & Novak's Gynecology

2. Adrenal Androgen-Secreting Tumor (Adrenocortical Carcinoma or Adenoma)

Adrenal tumors can produce massive androgen excess — testosterone, DHEAS, and androstenedione. Adrenocortical carcinoma in particular may co-secrete cortisol (causing Cushing features) alongside androgens. The sudden onset of virilization with elevated total testosterone is a red flag. Failure to suppress with dexamethasone distinguishes this from functional adrenal hyperandrogensim.

Key labs: Very high total testosterone ± high DHEAS; cortisol may be elevated; low LH/FSH
Workup: Abdominal CT/MRI adrenals; 24-hr urine cortisol; DHEAS — Fitzpatrick's Dermatology | Berek & Novak's Gynecology

3. Congenital Adrenal Hyperplasia — Classic or Non-Classic (21-Hydroxylase Deficiency)

Elevated 17-OHP is the hallmark clue here. In classic CAH (21-hydroxylase deficiency), cortisol synthesis is blocked, causing ACTH-driven accumulation of 17-OHP and shunting to androgens (testosterone, androstenedione, DHEAS). The elevated 17-OHP in this patient — combined with hyperandrogenism, amenorrhea, virilization, and suppressed gonadotropins — makes CAH a critical diagnosis to exclude. Non-classic (late-onset) CAH typically presents more mildly, but classic CAH presenting late or incompletely managed can produce the full virilization picture described.

Key labs: 17-OHP > 10 ng/mL (baseline); confirmed by ACTH stimulation test (17-OHP > 1500 ng/dL)
Note: Low LH/FSH in CAH results from androgen-mediated suppression of the hypothalamic-pituitary axis — Fitzpatrick's Dermatology | Berek & Novak's Gynecology | Textbook of Family Medicine 9e

4. Polycystic Ovarian Syndrome (PCOS) — Severe / Type I

PCOS is the most common cause of hyperandrogenism and chronic anovulation in reproductive-aged women. The acanthosis nigricans (lateral neck), insulin resistance, muscular/obese habitus, amenorrhea, and androgen excess with elevated free testosterone all fit. However, the degree of virilization (clitoromegaly, voice change, marked bitemporal recession) and very high total testosterone are atypically severe for PCOS alone — usually PCOS causes mild-moderate hirsutism without full virilization. Elevated 17-OHP can be mildly elevated in PCOS due to LH-driven ovarian theca cell stimulation. PCOS typically shows elevated or normal LH with low/normal FSH (LH:FSH ratio > 2:1), so the suppressed LH here points away from classic PCOS unless a co-secreting tumor or severe ovarian hyperthecosis is present.

Key labs: Elevated free testosterone, mildly elevated 17-OHP, insulin resistance, elevated LH:FSH (classically)
Workup: Pelvic ultrasound (polycystic ovaries); fasting insulin/glucose — Fitzpatrick's Dermatology | Andrews' Diseases of the Skin | Berek & Novak's Gynecology

5. Ovarian Hyperthecosis

A variant of PCOS in which islands of luteinized theca cells are scattered throughout the ovarian stroma, producing sustained and markedly elevated testosterone — often higher than in typical PCOS. Presents with severe hyperandrogenism, frank virilization, clitoromegaly, acanthosis nigricans, amenorrhea, and insulin resistance. Unlike typical PCOS, LH may not be elevated (or may even be suppressed). This diagnosis frequently mimics androgen-secreting tumors clinically and biochemically.

Key labs: Very high total testosterone, suppressed/normal LH and FSH, acanthosis nigricans
Workup: Pelvic ultrasound (bilaterally enlarged, smooth ovaries); selective venous sampling — Berek & Novak's Gynecology | Fitzpatrick's Dermatology

6. HAIR-AN Syndrome (Hyperandrogenism, Insulin Resistance, Acanthosis Nigricans)

HAIR-AN is a distinct syndrome found in 1–5% of women with hyperandrogenism. It is characterized by the triad: Hyperandrogenism, Acanthosis Nigricans, and profound Insulin Resistance (independent of obesity). The velvety tannish acanthosis nigricans of the lateral neck in this patient is a classic cutaneous marker. Compensatory hyperinsulinemia drives excess ovarian androgen production. LH/FSH may be suppressed by the androgen excess. Virilization can be severe.

Key labs: Elevated free/total testosterone, fasting hyperinsulinemia, normal or elevated 17-OHP
Workup: Fasting insulin, OGTT, testosterone fractionation — Fitzpatrick's Dermatology | Berek & Novak's Gynecology

7. Cushing Syndrome / Cushing Disease

Cortisol excess (from pituitary ACTH-secreting adenoma, adrenal adenoma/carcinoma, or ectopic ACTH) can cause adrenal androgen overproduction, leading to hirsutism, acne, acanthosis nigricans, menstrual irregularity, and virilization. The muscular/obese habitus could be explained by hypercortisolism (though typically Cushing causes centripetal obesity rather than a muscular habitus). Adrenocortical carcinomas may co-produce cortisol and androgens simultaneously — making Cushing + virilization overlap relevant here.

Key labs: Elevated 24-hr urine free cortisol; failed overnight dexamethasone suppression; elevated DHEAS
Workup: Late-night salivary cortisol; low-dose dexamethasone suppression test; pituitary MRI — Fitzpatrick's Dermatology | Harrison's Principles of Internal Medicine 22E

8. Non-Classic (Late-Onset) CAH — 11β-Hydroxylase Deficiency

The second most common form of CAH. 11β-hydroxylase deficiency leads to accumulation of 11-deoxycortisol and 11-deoxycorticosterone, shunting to adrenal androgens. 17-OHP is elevated (though less dramatically than in 21-hydroxylase deficiency). Presents with virilization, hirsutism, amenorrhea, and acne. The biochemical picture (high 17-OHP, high testosterone, suppressed LH/FSH) is very consistent with this patient's labs.

Key labs: Elevated 17-OHP, elevated 11-deoxycortisol, suppressed renin/aldosterone; may have hypertension
Workup: ACTH stimulation test with measurement of 11-deoxycortisol — Berek & Novak's Gynecology

9. Non-Classic CAH — 3β-Hydroxysteroid Dehydrogenase (3β-HSD) Deficiency

3β-HSD deficiency impairs conversion of Δ5 steroids (pregnenolone → progesterone; 17-OH-pregnenolone → 17-OHP; DHEA → androstenedione). The resulting androgen excess produces hirsutism, menstrual irregularity, and virilization. 17-OHP is elevated in this condition (though mildly, and the ratio of Δ5/Δ4 steroids is more discriminating). This is a less common but important CAH variant to consider when 17-OHP is elevated.

Key labs: Mildly elevated 17-OHP, elevated DHEA/DHEAS, elevated 17-hydroxypregnenolone
Workup: ACTH stimulation test; steroid profile by mass spectrometry — Berek & Novak's Gynecology

10. Hilus (Leydig) Cell Tumor of the Ovary

Hilus cell tumors arise from Leydig-like cells in the ovarian hilum and are the most androgenic of all ovarian tumors, often producing testosterone levels exceeding 200 ng/dL. They cause rapid-onset, severe virilization — clitoromegaly, voice deepening, bitemporal alopecia — with suppressed LH and FSH. Usually small and may be missed on ultrasound; require MRI or selective ovarian vein sampling.

Key labs: Very high total testosterone, suppressed LH/FSH
Workup: Pelvic MRI; selective venous catheterization; inhibin — Berek & Novak's Gynecology | Fitzpatrick's Dermatology

11. Lipoid Cell Tumor (Steroid Cell Tumor NOS) of the Ovary

Steroid cell tumors NOS (not otherwise specified) are rare ovarian tumors that can produce testosterone, cortisol, and other steroids. They present with progressive virilization — hirsutism, clitoromegaly, voice deepening, amenorrhea, androgenetic alopecia — and may produce acanthosis nigricans through insulin resistance-like mechanisms. Testosterone levels are markedly elevated.

Key labs: High testosterone ± high cortisol, suppressed LH/FSH
Workup: Pelvic ultrasound/MRI; 24-hr urine steroids — Berek & Novak's Gynecology

12. Exogenous Androgen / Anabolic Steroid Use

The muscular habitus in this patient is an important contextual clue. Exogenous anabolic steroids (testosterone, nandrolone, oxandrolone, DHEA supplements) cause exogenous hyperandrogenism with identical clinical features: androgenetic alopecia (bitemporal + vertex), hirsutism, clitoromegaly, voice deepening, amenorrhea, acanthosis nigricans (via insulin resistance), and suppressed LH/FSH (exogenous androgen suppresses the hypothalamic-pituitary axis). This diagnosis must always be excluded by history and urine/serum drug screening.

Key labs: Suppressed LH/FSH, high testosterone (exogenous source), potentially elevated 17-OHP depending on compound
Workup: Detailed drug/supplement history; urine drug screen; testosterone/epitestosterone ratio — Fitzpatrick's Dermatology | Andrews' Diseases of the Skin

13. Prolactin-Secreting Pituitary Adenoma (Prolactinoma) with Secondary Hyperandrogenism

Hyperprolactinemia causes amenorrhea by suppressing GnRH pulsatility → suppressed LH and FSH. Prolactin also directly stimulates adrenal DHEAS production, contributing to androgen excess, hirsutism, and acne. While prolactinoma alone rarely causes full virilization, it can present with amenorrhea + mild-to-moderate hirsutism + suppressed LH/FSH — and could coexist with PCOS or another androgen-excess state. The suppressed gonadotropins fit this diagnosis well.

Key labs: Elevated prolactin; suppressed LH/FSH; mildly elevated DHEAS/androgens
Workup: Serum prolactin; pituitary MRI — Fitzpatrick's Dermatology | Berek & Novak's Gynecology

14. Hypothyroidism

Hypothyroidism is associated with diffuse scalp hair loss, coarsening of skin, and menstrual irregularity (including amenorrhea). Severe hypothyroidism can cause elevated TBG which alters sex hormone binding, and can be associated with hyperprolactinemia (via TRH cross-stimulation of prolactin) → secondary LH/FSH suppression. While it does not typically cause true hyperandrogenism, it should be excluded in any woman with diffuse hair loss and menstrual dysfunction, especially when the scalp shows scaling/erythema overlapping with seborrheic patterns.

Key labs: Elevated TSH, low free T4; prolactin may be elevated
Workup: TSH, free T4 — Fitzpatrick's Dermatology | Textbook of Family Medicine 9e

15. Androgen Receptor Hypersensitivity / Idiopathic Hyperandrogenism (SAHA Syndrome)

SAHA syndrome (Seborrhea, Acne, Hirsutism, Androgenetic alopecia) represents a spectrum of androgen receptor or 5α-reductase hypersensitivity in the skin, where clinical signs of hyperandrogenism occur with normal or minimally elevated circulating androgens. However, when combined with the severe labs and clinical signs described (especially the very high testosterone, suppressed gonadotropins, clitoromegaly), this diagnosis would apply as a contributory/overlapping mechanism — amplifying the end-organ response even if an underlying source is primary. The scalp miniaturization with scaling/erythema fits the androgen-driven seborrheic dermatitis pattern of SAHA.

Key labs: Can be normal or minimally elevated androgens; no ovarian/adrenal tumor identified
Workup: Exclusion of other causes; 5α-reductase activity; androgen receptor studies — Fitzpatrick's Dermatology

Summary Prioritization Table

#	Diagnosis	Most Discriminating Feature
1	Sertoli-Leydig Cell Tumor	Testosterone > 200 ng/dL, pelvic mass, rapid virilization
2	Adrenocortical Carcinoma/Adenoma	Very high DHEAS, adrenal mass on CT
3	CAH — 21-OH Deficiency (classic/non-classic)	High 17-OHP, ACTH stimulation test
4	PCOS (severe)	Polycystic ovaries, LH:FSH > 2, insulin resistance
5	Ovarian Hyperthecosis	Bilaterally enlarged ovaries, severe virilization, high testosterone
6	HAIR-AN Syndrome	Acanthosis nigricans, profound insulin resistance
7	Cushing Syndrome	Elevated cortisol, failed dexamethasone suppression
8	CAH — 11β-OH Deficiency	Hypertension, elevated 11-deoxycortisol
9	CAH — 3β-HSD Deficiency	Elevated DHEA/17-hydroxypregnenolone
10	Hilus (Leydig) Cell Tumor	Extremely high testosterone, small ovarian hilum mass
11	Steroid Cell Tumor NOS	Testosterone ± cortisol, ovarian mass
12	Exogenous Androgen Use	Muscular habitus, drug history, testosterone/epitestosterone ratio
13	Prolactinoma	Elevated prolactin, pituitary MRI lesion
14	Hypothyroidism	Elevated TSH, diffuse hair loss without true virilization
15	SAHA / Idiopathic Hyperandrogenism	End-organ amplification, exclusion diagnosis

Critical Next Steps (highest yield):

Pelvic MRI/ultrasound — exclude ovarian tumor (Sertoli-Leydig, hilus cell, hyperthecosis)
Abdominal CT adrenals — exclude adrenocortical carcinoma/adenoma
ACTH stimulation test with 17-OHP and 11-deoxycortisol — confirm or exclude CAH subtypes
Serum DHEAS, prolactin, TSH, cortisol — screen adrenal, pituitary, thyroid contributions
Detailed medication/supplement history — exclude exogenous anabolic steroid use
Dexamethasone suppression test — differentiate ACTH-dependent vs. autonomous androgen excess

Sources: Fitzpatrick's Dermatology (Vol. 1/2, 8e) | Andrews' Diseases of the Skin | Berek & Novak's Gynecology | Dermatology 2-Volume Set, 5e | Textbook of Family Medicine, 9e | Harrison's Principles of Internal Medicine, 22e

This is a shared conversation. Sign in to Orris to start your own chat.